Albany, New York (09/24/2014) – Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) has received fast track status for its product candidate, Aramchol. The designation is given by FDA to accelerate the development process. Aramchol is the drug candidate of Galmed to treat the patients suffering from Non-Alcoholic…